ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation

Influenza Other Respir Viruses. 2016 May;10(3):152-3. doi: 10.1111/irv.12377.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Clinical Trials as Topic
  • Enzyme Inhibitors / therapeutic use
  • European Union
  • Expert Testimony
  • Health Policy
  • Humans
  • Influenza, Human / drug therapy*
  • Meta-Analysis as Topic
  • Neuraminidase / antagonists & inhibitors*
  • Treatment Outcome
  • Zanamivir / therapeutic use

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Neuraminidase
  • Zanamivir